{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:42:47Z","timestamp":1780094567516,"version":"3.54.0"},"reference-count":84,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Previous work suggests a role for dopamine D3\u2010like receptors in psychostimulant reinforcement. The development of new compounds acting selectively at dopamine D3 receptors has opened new possibilities to explore the role of these receptors in animal models of psychostimulant dependence. Here we investigated whether the dopamine D3 partial agonist CJB090 (1\u201310\u2003mg\/kg, i.v) and the D3 antagonist PG01037 (8\u201332\u2003mg\/kg, s.c.) modified methamphetamine (0.05\u2003mg\/kg\/injection) intravenous self\u2010administration under fixed\u2010 (FR) and progressive\u2010 (PR) ratio schedules in rats allowed limited (short access, ShA; 1\u2010hour sessions 3 days\/week) or extended access (long access, LgA; 6 hour sessions 6 days\/week). Under a FR1 schedule, the highest dose of the D3 partial agonist CJB090 selectively reduced methamphetamine self\u2010administration in LgA but not in ShA rats, whereas the full D3 antagonist PG01037 produced no effect in either group. Under a PR schedule of reinforcement, the D3 partial agonist CJB090 reduced the maximum number of responses performed (\u2018breakpoint\u2019) for methamphetamine in LgA rats at the doses of 5 and 10\u2003mg\/kg, and also it produced a significant reduction in the ShA group at the highest dose. However, the D3 full antagonist PG01037 only reduced PR methamphetamine self\u2010administration in LgA rats at the highest dose of 32\u2003mg\/kg with no effect in the ShA group. The results suggest that rats might be more sensitive to pharmacological modulation of dopamine D3 receptors following extended access to methamphetamine self\u2010administration, opening the possibility that D3 receptors play a role in excessive methamphetamine intake.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2010.00211.x","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T08:00:14Z","timestamp":1272614414000},"page":"312-323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["PRECLINICAL STUDY: FULL ARTICLE: The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended\u2010access"],"prefix":"10.1111","volume":"15","author":[{"given":"Laura","family":"Orio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmee","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1581-9"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5387.298"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1682-9"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200201210-00039"},{"key":"e_1_2_7_7_1","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt RC","year":"1982"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200102000-00001"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8099761"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.133181"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.144048"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.085472"},{"key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0090-9556(25)07478-1","article-title":"Pharmacokinetics of methamphetamine self\u2010administered to human subjects by smoking S\u2010(+)\u2010methamphetamine hydrochloride","volume":"21","author":"Cook CE","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.06.033"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.5.1025"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801950572"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90071-O"},{"key":"e_1_2_7_19_1","first-page":"625","article-title":"Methamphetamine. Stimulant of the 1990s?","volume":"153","author":"Derlet RW","year":"1990","journal-title":"West J Med"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300148"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1310-0"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300276"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105140"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200410050-00021"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00300-7"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.011"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00247-N"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20152"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464140-00004"},{"key":"e_1_2_7_30_1","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing L","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049465g"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0704200"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e3181602fab"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152708786927822"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2004.12.033"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.02.023"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(93)90129-8"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969100-00003"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0353-z"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90060-J"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.012"},{"key":"e_1_2_7_42_1","first-page":"1","article-title":"Role for the mesocortical dopamine system in the motivating effects of cocaine","volume":"145","author":"Koob GF","year":"1994","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2828"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.01.019"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.02049.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.04.022"},{"key":"e_1_2_7_47_1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300622","article-title":"Dopamine D3 receptor ligands block nicotine\u2010induced conditioned place preferences through a mechanism that does not involve discriminative\u2010stimulus or antidepressant\u2010like effects","volume":"30","author":"Le FB","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.1.45"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.17.8155"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300575"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2505-07.2007"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.113571"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801919460"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00171-8"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801923710"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20365"},{"key":"e_1_2_7_57_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-3565(25)10706-4","article-title":"Pharmacokinetic and pharmacodynamic analysis of the actions of d\u2010amphetamine and d\u2010methamphetamine on the dopamine terminal","volume":"274","author":"Melega WP","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0705612"},{"key":"e_1_2_7_59_1","first-page":"42","volume-title":"Toxicokinetics and New Drug Development","author":"Mordenti J","year":"1989"},{"key":"e_1_2_7_60_1","unstructured":"National Institute on Drug Abuse(2005)Medications Development Research for Treatment of Amphetamine and Methamphetamine Addiction. Report to Congree. National Institutes of Health Department of Health and Human Services (http:\/\/www.nida.nih.gov\/pdf\/methmeds.pdf)"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(03)00389-5"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900095y"},{"key":"e_1_2_7_63_1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0026-895X(24)12183-9","article-title":"G protein activation by human dopamine D3 receptors in high\u2010expressing Chinese hamster ovary cells: a guanosine\u20105\u2032\u2010O\u2010(3\u2010[35S]thio)\u2010 triphosphate binding and antibody study","volume":"55","author":"Newman\u2010Tancredi A","year":"1999","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0563-09.2009"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145706006560"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200312020-00019"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/22560"},{"key":"e_1_2_7_68_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-3565(24)37716-X","article-title":"Characterization of the effects of the partial dopamine agonist terguride on cocaine self\u2010administration in the rat","volume":"286","author":"Pulvirenti L","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90158-9"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01991-X"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(95)00153-0"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01550-9"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(97)00025-9"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/347146a0"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0986-6"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.05.022"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2008.00783.x"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301353"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.969"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199502000-00010"},{"key":"e_1_2_7_83_1","first-page":"S10","article-title":"Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment","volume":"52","author":"Wolters EC","year":"1999","journal-title":"Neurology"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1858-y"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04159.x"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2010.00211.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2010.00211.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:19:27Z","timestamp":1740053967000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2010.00211.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1369-1600.2010.00211.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2010.00211.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]},"assertion":[{"value":"2010-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}